Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for Alcohol Dependence (BACLAD)
NCT01266655Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence comparing Baclofen with Placebo (2 arms). Primary endpoint: Total abstinence from alcohol and cumulative abstinence duration. Started Feb 2011; status: completed.
02
Drugs
baclofen
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT01266655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01266655.